Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion evidence source_evidence_literature NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion SIO_000772 20623637 NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion wasDerivedFrom befree-20150227 NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion wasGeneratedBy ECO_0000203 NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.